Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

about

Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1).High-volume continuous venovenous hemodiafiltration plus resin hemoperfusion improves severe metformin-associated toxicity.

P2860

Q47230742-639678CA-F6E1-41BD-AA9D-B1B14A702A26 Q47619212-EB009137-C786-48D7-83FC-D19F0178DE17

P2860

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

Item

http://www.wikidata.org/entity/Q36737021

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

@ast

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

@en

type

Item

label

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

@ast

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

@en

prefLabel

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

@ast

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

@en

P1476

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

@en

P2093

Dong Guo

http://www.w3.org/2001/XMLSchema#string

Hong Yang

http://www.w3.org/2001/XMLSchema#string

Honghao Zhou

http://www.w3.org/2001/XMLSchema#string

James E Polli

http://www.w3.org/2001/XMLSchema#string

Qing Li

http://www.w3.org/2001/XMLSchema#string

Taolan Zhang

http://www.w3.org/2001/XMLSchema#string

Yan Shu

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of cancer in diabetes: the effect of metformin

A human transporter protein that mediates the final excretion step for toxic organic cations

Applications of CYP450 testing in the clinical setting

Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs

Membrane transporters as mediators of Cisplatin effects and side effects.

Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.

New perspective for an old antidiabetic drug: metformin as anticancer agent.

Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins.

P304

489-494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.115.067223

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292346425

http://www.w3.org/2001/XMLSchema#string

P698

26825640

http://www.w3.org/2001/XMLSchema#string

P932

4810771

http://www.w3.org/2001/XMLSchema#string

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

about

P2860

P2860

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932